MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

Model Number	PLC201400
Medical Device Problem Code	Patient-Device Incompatibility (2682)
Health Effect - Clinical Codes	Aneurysm (1708); Clinical Endoleak (4843)
Date of Event	06/21/2022
Type of Reportable Event	Serious Injury
Event or Problem Description
On (b)(6) 2018, it was reported to gore that a patient with a partially thrombosed infrarenal aortic aneurysm with a maximum diameter of 6.9 x 8.2 cm was treated with gore® excluder® aaa endoprosthesis (rlt 281414, with the ipsilateral leg on the right).This right side was then lengthened with another graft (plc 201400, sn (b)(4)).A third gore® excluder® aaa endoprosthesis was implanted on the contralateral (left) side (plc 201400, sn (b)(4)).Both the main body with lengthening and the contralateral leg are dilated with a 33 mm diameter balloon (equalizer balloon catheter, boston scientific).The subsequent angiography shows that the prosthesis is properly seated.The infrarenal abdominal aortic aneurysm could be eliminated.No evidence of an endoleak.On (b)(6) 2022, it was reported that the patient underwent embolization of the left internal iliac artery, with an extension of the left leg until the external iliac artery on (b)(6) 2022 using an additional gore® excluder® aaa endoprosthesis (stent graft contralateral leg).The reason for the reintervention is a type 1b endoleak with connecting aneurysm distal to the implant.
Additional Manufacturer Narrative
Concomitant medical products: gore® excluder® aaa endoprosthesis - stent graft trunk ipsilateral leg c3 (rlt281414); gore® excluder® aaa endoprosthesis - stent graft contralateral leg endoprosthesis (plc201400).(b)(4).Per gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to: endoleak.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
Additional Manufacturer Narrative
Updated h6: added health effect - clinical code e2121 - endoleaks.Updated health effect - impact code to f1901 - additional surgery.Code 4642 was inadvertently entered, but correct code should be 4641.Updated investigation findings code to c19 - no device problem found.Code 3233 is no longer applicable.Updated investigation conclusions code to d15 and d12.Code 11 is no longer applicable.A review of the manufacturing records indicated the lot met pre-release manufacturing specifications.

• Brand Name: GORE® EXCLUDER® AAA ENDOPROSTHESIS
• Common Device Name: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
• Manufacturer (Section D): W. L. GORE & ASSOCIATES, INC.; 1505 n. fourth street; flagstaff AZ 86004
• Manufacturer (Section G): MEDICAL SUNNYVALE B/P; 1327 orleans drive; sunnyvale CA 94089
• Manufacturer Contact: ida simson ; 1505 n. fourth street; flagstaff, AZ 86004 ; 9285263030
• MDR Report Key: 15040782
• Report Number: 2953161-2022-01139
• Device Sequence Number: 5049888
• Product Code: MIH
• UDI-Device Identifier: 00733132618552
• UDI-Public: 00733132618552
• Combination Product (Y/N): N
• Initial Reporter Country: GM
• PMA/510(K) Number: P020004
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2018
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Foreign,Company Representative
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup
• Report Date (Section B): 09/19/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Expiration Date: 02/09/2020
• Device Model Number: PLC201400
• Device Catalogue Number: PLC201400
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Initial
• Initial Date Received by Manufacturer: 06/23/2022
• Supplement Date Received by Manufacturer: 09/16/2022
• Initial Report FDA Received Date: 07/18/2022
• Supplement Report FDA Received Date: 09/19/2022
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 02/09/2017
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: SEE H10
• Outcome Attributed to Adverse Event: Other
• Patient Age: 72 YR
• Patient Sex: Male